System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Stéphane Barete is an expert in Dermatology at Pitié-Salpêtrière Hospital (France). Stéphane Barete has authored 297 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 2 of them ongoing. SLR score: 622 (community average: 125). How the SLR is computed.

LeadR Profile

Stéphane Barete Pitié-Salpêtrière Hospital France
622 ScienceLeadR Reputation 622

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Immunology - Hematology - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

MD in dermatology in a University hospital in Paris. PhD for rare diseases especially mastocytosis, autoimmune diseases and organ transplant patients. Interested in clinical research for these pathologies.

Organizations

Career arc: 2026 - 2026
Source: PubMed

Pitié-Salpêtrière Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 297

Citations

Citations: 6 629 1st author: 13 Last author: 18 Unique author: 4

Main journals

Ann Dermatol Venereol 45
Rev Med Interne 44
Blood 12
J Allergy Clin Immunol 12
J Am Acad Dermatol 11

Best Journals

J Clin Oncol 2
N Engl J Med 2
Nat Med 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
MEK inhibition achieves robust and durable responses in Erdheim-Chester disease.
PMID 42840804 — safety, erdheim-chester disease, probability, therapeutics, retention, psychology		Hemasphere20260
CBL Variants in Suspected Histiocytic Neoplasms: A Retrospective Study of 11 Cases.
PMID 42758873 — hematology, retrospective studies, neoplasms		Hematol Oncol20260
Oral Relapsing Lymphomatoid Papulosis: A Case Report.
PMID 42746506 — cells, oral medicine, lymphoma, lymphomatoid papulosis, lymphoproliferative disorders, mouth		Clin Case Rep20260
Management of mucocutaneous and joint involvement of Behçet's syndrome: a systematic literature review informing the 2025 update of the EULAR recommendations.
PMID 42540112 — quality of life, behcet syndrome, ulcer, adalimumab		EULAR Rheumatol Open20265
Management of major organ involvement in Behçet syndrome: a systematic literature review informing the 2025 update of the EULAR recommendations.
PMID 42540035 — behcet syndrome, interferon-alpha, necrosis, therapeutics, nervous system		EULAR Rheumatol Open20263

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 2
Phase 2 1
Phase 3 1
Phase 4 1

By status:

Active not recruiting 2
Recruiting 2
Completed 1

By type:

Interventional 3
Observational 2

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 4

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Epidemiological Data on Mast Cell Pathologies in France
NCT06186856 — cells, leukemia, mast-cell, pathology, mastocytosis, mast cells		N/ARecruiting2024
Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus
NCT05898308 — injections, skin, antibodies, adrenal cortex hormones, skin diseases, desmogleins, biomarkers, maintenance, rituximab, precision medicine, acantholysis, therapeutics, pemphigus		Phase 4Recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS